Cancer Clinical Trials: 2 RCCA Oncologists Separate Fact from Fiction
Iron deficiency and the anemia that can result from it are serious conditions Learn more from Regional Cancer Care Associates
Dr. David Siegel featured in The Wall Street Journal
In case you missed it, two new drugs for multiple myeloma have been approved and are expected to extend life expectancy for patients with the blood cancer.
Dr. Siegel, one of the nation’s foremost authorities on multiple myeloma, shares his thoughts in an article from The Wall Street Journal.
David S. Siegel, M.D., Ph.D., is Chief of the Myeloma Division at John Theurer Cancer Center in Hackensack, N.J.
we are here for you
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
RELATED ARTICLES
Iron Deficiency and Iron Deficiency Anemia: What You Need to Know
Iron deficiency and the anemia that can result from it are serious conditions Learn more from Regional Cancer Care Associates
Progress Against Cervical Cancer: 2 RCCA Oncologists Discuss Advances in Prevention and Treatment
The outlook for treating and preventing cervical cancer is brighter thanks to new treatment options. Learn more from Regional Cancer Care Associates.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.